Aditxt (ADTX) Cash from Operations (QoQ) (2019 - 2026)
Aditxt (ADTX) Cash from Operations (QoQ) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Aditxt |
2,485.68 |
-2.16 Mn |
2,868.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
50.48% |
| Dec 31, 2025 |
-294.35% |
| Sep 30, 2025 |
1.69% |
| Jun 30, 2025 |
79.64% |
| Mar 31, 2025 |
-90.55% |
| Dec 31, 2024 |
-159.99% |
| Sep 30, 2024 |
-3.25% |
| Jun 30, 2024 |
61.59% |
| Mar 31, 2024 |
-51.44% |
| Dec 31, 2023 |
51.01% |
| Sep 30, 2023 |
-144.80% |
| Jun 30, 2023 |
16.95% |
| Mar 31, 2023 |
41.19% |
| Dec 31, 2022 |
14.05% |
| Sep 30, 2022 |
-194.56% |
| Jun 30, 2022 |
48.95% |
| Mar 31, 2022 |
40.18% |
| Dec 31, 2021 |
-92.03% |
| Sep 30, 2021 |
9.61% |
| Jun 30, 2021 |
-23.52% |
